Agnes Viale

Shared Resource Management (SRM) is critical to demonstrating the scientific, operational, and strategic value of shared resources (SRs) within NCI-designated Cancer Centers, particularly during quinquennial Cancer Center Support Grant (CCSG) renewal. SRs provide advanced technologies, specialized expertise, and coordinated infrastructure that support basic, translational, and clinical research. Within this framework, SRM advances three core aims: sustaining state-of-the-art resources, centralizing operational and financial management, and fostering innovation to meet emerging scientific needs. This paper examines SRM through the following aims, highlighting its importance for CCSG preparation, institutional competitiveness, and adaptation to a changing NIH funding landscape. Despite evolving review expectations and funding uncertainty, effective SRM remains essential to cancer center resilience and research excellence.

Genomically matched targeted therapies guided by MSK-IMPACT testing (n=22).

Clonality assessment of known oncogenic mutations in the female GCT cohort.

Patient demographic data for the female patients in the Extragonadal GCT cohort (both Make-an-IMPACT and internal MSK patients, n=16)

Supplemental Table 2 from Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Supplemental Table 3 from Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Supplemental Figure 4 from Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Supplemental Figure 3 from Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer